Posters

Comparison between biaxial and coaxial phacoemulsification in cases of cataract surgery in eyes with corneal opacities, using only the microscope light

Poster Details

First Author: A.Pérez Arteaga MEXICO

Co Author(s):    M. Pérez-Sáenz                    

Abstract Details

Purpose:

To compare the safety and efficacy of biaxial versus coaxial cataract surgery in eyes with corneal opacities, using only the microscope as source of light.

Setting:

Centro Oftalmologico Tlalnepantla, Mexico

Methods:

32 cases of cataract surgery in eyes with corneal opacity were operated by one surgeon with the use of Biaxial Phacoemulsification, with out an additional source of light, rather than the microscope light. Variables like incision size, capsulorhexis integrity, phacoemulsification time, amount of balance salt solution (BSS) utilized, intraocular (IOL) lens centration and intraoperative posterior capsule rupture were measured and compared with data of previous 17 cases operated by the same surgeon with Coaxial Phacoemulsification. Subjective variables were measured (from + to ++++ ) like accessibility, visibility and better maneuver performance

Results:

The Biaxial approach was statistically significative better than the Coaxial in incision size, capsulorhexis integrity, phacoemulsification time, amount of BSS used, postoperative IOL centration and rate of intraoperative posterior capsule rupture. Subjective variables also indicates improvement in the performance of Biaxial approach

Conclusions:

Biaxial Phacoemulsification is a safe and effective technique to perform Cataract Surgery in eyes with corneal opacities. Further work should be done to study Biaxial approach with endoilumination in comparison to Coaxial

Financial Disclosure:

gains financially from competing product or procedure, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, is employed by a competing company, has significant investment interest in a company producing, developing or supplying product or procedure presented